Literature DB >> 15908359

Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics.

Antje Blumenthal1, Jörg Lauber, Reinhard Hoffmann, Martin Ernst, Christine Keller, Jan Buer, Stefan Ehlers, Norbert Reiling.   

Abstract

Classification of pathogenic species according to the distinct host transcriptional responses that they elicit may become a relevant tool for microarray-based diagnosis of infection. Individual strains of Mycobacterium avium, an opportunistic pathogen in humans, have previously been shown to differ in terms of growth and persistence. In order to cover a wide spectrum of virulence, we selected four M. avium isolates (2151SmO, 2151SmT, SE01, TMC724) that have distinct intramacrophage replication characteristics and cause differential activation in human macrophages. Following infection with each of these strains, the expression of 12,558 genes in human macrophages was systematically analyzed by microarray technology. Fifty genes (including genes encoding proinflammatory cytokines, chemokines, signaling, and adhesion molecules) were differentially expressed more than twofold in response to all of the M. avium isolates investigated and therefore constitute a common macrophage signature in response to M. avium. The magnitude of regulation of most of these genes was directly correlated with the host cell-activating capacity of the particular M. avium strain. The regulation of a number of genes not previously associated with mycobacterial infections was apparent; these genes included genes encoding lymphocyte antigen 64 and myosin X. In addition, individual response patterns typical for some M. avium isolates could be defined by the pronounced upregulation of interleukin-12p40 (IL-12p40) (in the case of 2151SmO) or the specific upregulation of SOCS-1 and IL-10 (in the case of SE01) in macrophages. TMC724, a strain of avian origin, could not be classified by any one of these schemes, possibly indicating the limits of pathogen categorization solely by immune response signatures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908359      PMCID: PMC1111816          DOI: 10.1128/IAI.73.6.3330-3341.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium.

Authors:  J Benini; E M Ehlers; S Ehlers
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 3.  Immunopathogenesis of Mycobacterium avium infection.

Authors:  A M Cooper; R Appelberg; I M Orme
Journal:  Front Biosci       Date:  1998-08-05

4.  The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.

Authors:  R Appelberg; A M Sarmento
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

5.  Mycobacterium avium complex and the normal host: the other side of the coin.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

6.  [Horseradish peroxidase: kinetic studies and optimization of peroxidase activity determination using the substrates H2O2 and 3,3',5,5'-tetramethylbenzidine].

Authors:  H Gallati; I Pracht
Journal:  J Clin Chem Clin Biochem       Date:  1985-08

7.  Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression.

Authors:  J T Belisle; K Klaczkiewicz; P J Brennan; W R Jacobs; J M Inamine
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

Review 8.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor.

Authors:  S K Furney; P S Skinner; A D Roberts; R Appelberg; I M Orme
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Expression profiling in granulomatous lung disease.

Authors:  Edward S Chen; David R Moller
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages.

Authors:  Fabio Martinon; Xi Chen; Ann-Hwee Lee; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

Review 3.  Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?

Authors:  Rui Appelberg
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.

Authors:  Sarah L Young; Lynn Slobbe; Rachel Wilson; Bryce M Buddle; Geofferey W de Lisle; Glenn S Buchan
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  CCL20 is overexpressed in Mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS).

Authors:  O M Rivero-Lezcano; C González-Cortés; D Reyes-Ruvalcaba; C Diez-Tascón
Journal:  Clin Exp Immunol       Date:  2010-09-01       Impact factor: 4.330

6.  Comparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes.

Authors:  Alifiya S Motiwala; Harish K Janagama; Michael L Paustian; Xiaochun Zhu; John P Bannantine; Vivek Kapur; Srinand Sreevatsan
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

7.  Mycobacterium avium serovars 2 and 8 infections elicit unique activation of the host macrophage immune responses.

Authors:  B R Cebula; J M Rocco; J N Maslow; V R Irani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-19       Impact factor: 3.267

8.  Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis.

Authors:  S Franco-Martínez; P Niño-Moreno; S Bernal-Silva; L Baranda; M Rocha-Meza; L Portales-Cervantes; E Layseca-Espinosa; R González-Amaro; D Portales-Pérez
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

9.  Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.

Authors:  Manish Bodas; Taehong Min; Steven Mazur; Neeraj Vij
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

10.  Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells.

Authors:  Elizabeth P Sampaio; Houda Z Elloumi; Adrian Zelazny; Li Ding; Michelle L Paulson; Alan Sher; Andre L Bafica; Yvonne R Shea; Steven M Holland
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-25       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.